IMW 2019 | Promising outlook for MM patients
Gösta Gahrton, MD, of Karolinska University Hospital, Stockholm, Sweden, talks about the outlook for multiple myeloma patients. Dr Gahrton suggests that new drugs should be combined with approaches such as allogeneic transplants, CAR-T cells and CAR-NK cells. This interview took place at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
Get great new content delivered to your inboxSign up